Skip to main content

Advertisement

FDA approves first cell therapy to treat aggressive forms of melanoma

Amtagvi is the first cell therapy for solid tumors approved by the FDA. (Iovance Biotherapeutics, Inc.)
Amtagvi is the first cell therapy for solid tumors approved by the FDA. (Iovance Biotherapeutics, Inc.)

Related:

Advertisement

Advertisement

Listen Live